AGI Therapeutics cuts net loss from $18.2m to $10.6m

Pharmaceutical company AGI Therapeutics has reduced its net loss from $18.2m (€13.3m) in 2008 to $10.6m (€7.8m) last year, the company said today, leading to a loss per ordinary share of 15.8c.

Last year, the Dublin-headquartered company closed its US office, reducing its overall headcount, and halved day-to-day running costs.